A phase 3, double-blind, randomized, placebo-controlled study of the safety and efficacy of adefovir dipivoxil in children and adolescents (age 2 to less than 18) with chronic hepatitis B.

Trial Profile

A phase 3, double-blind, randomized, placebo-controlled study of the safety and efficacy of adefovir dipivoxil in children and adolescents (age 2 to less than 18) with chronic hepatitis B.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 May 2012

At a glance

  • Drugs Adefovir dipivoxil (Primary)
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Jun 2011 Additional lead investigator (John Flaherty) added as reported by ClinicalTrials.gov.
    • 01 Jun 2008 Results have been published in Hepatology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top